Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03158064
Brief Title: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

First Submitted : May 16, 2017
First Submitted that Met QC Criteria : May 16, 2017
First Posted : May 17, 2017

Last Update Submitted that Met QC Criteria : November 16, 2020
Last Update Posted : November 18, 2020